Stress Urinary Incontinence in Women With Multiple Sclerosis
UROSEP
Prevalence and Risk Factors of Stress Urinary Incontinence in Women With Multiple Sclerosis
1 other identifier
observational
363
0 countries
N/A
Brief Summary
Objective: To report the prevalence and risk factors of stress urinary incontinence (SUI) and the prevalence of intrinsic sphincter deficiency in women with multiple sclerosis (MS). Methods: A retrospective study was conducted among Female patients with MS, followed for lower urinary tract symptoms (LUTS) during a 15-year period. Demographic data, MS history, expanded disability status scale (EDSS) score at the urodynamic visit, obstetrical past, birth weight, LUTS, and urodynamic findings were collected. SUI was defined as incontinence during cough, or any effort. A maximum urethral closure pressure less than 30 cm H2O defined intrinsic sphincter deficiency. Results: In total 363 women with a mean age of 46.7±10.8 years and a mean disease duration of 12.9±8.7 years were included. The incidence of relapsing remitting MS, a secondary progressive form, and a primary progressive form was 60.6%, 32.8%, and 6.6%, respectively. The prevalence of SUI was 31.4%. The prevalence of intrinsic sphincter deficiency was 1.4% and 0.8% of these patients had a SUI (P=0.300). In a multivariate analysis, women with a SUI had significantly higher birth weight (P=0.030), a pelvic organ prolapse (P=0.021), urgent urinary incontinence (P=0.006), a lower EDSS score (P=0.019), and a weaker containing effort (P\<0.001). Conclusions: The prevalence of SUI in women with MS was 31.4%. This symptom could affect the quality of life of women with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2016
CompletedFirst Submitted
Initial submission to the registry
November 2, 2017
CompletedFirst Posted
Study publicly available on registry
November 6, 2017
CompletedNovember 6, 2017
November 1, 2017
12 months
November 2, 2017
November 2, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stress urinary incontinence
at inclusion
Study Arms (1)
Multiple sclerosis
Prevalence and risk factor of stress urinary incontinence in women with multiple sclerosis and included in the database over 15 years from December 1999 to June 2014, who had undergone a urodynamic test
Interventions
Eligibility Criteria
All women aged \>18 years with multiple sclerosis, who had undergone a urodynamic test for lower urinary tract symptoms were included
You may qualify if:
- Women aged \>18 years
- Multiple sclerosis
- Urodynamic test for lower urinary tract symptoms
- Followed in Saint Philibert Hospital between December 1999 to June 2014
You may not qualify if:
- Non confirmation of diagnosis of Multiple sclerosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cecile Donzé, MD
GHICL
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 2, 2017
First Posted
November 6, 2017
Study Start
February 1, 2015
Primary Completion
January 31, 2016
Study Completion
March 31, 2016
Last Updated
November 6, 2017
Record last verified: 2017-11